annual FCF:
-$42.59M-$84.53M(-201.54%)Summary
- As of today (May 29, 2025), ALNY annual free cash flow is -$42.59 million, with the most recent change of -$84.53 million (-201.54%) on December 31, 2024.
- During the last 3 years, ALNY annual FCF has risen by +$675.48 million (+94.07%).
- ALNY annual FCF is now -122.57% below its all-time high of $188.73 million, reached on December 31, 2007.
Performance
ALNY Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$127.28M-$23.53M(-22.68%)Summary
- As of today (May 29, 2025), ALNY quarterly free cash flow is -$127.28 million, with the most recent change of -$23.53 million (-22.68%) on March 31, 2025.
- Over the past year, ALNY quarterly FCF has dropped by -$32.80 million (-34.71%).
- ALNY quarterly FCF is now -137.18% below its all-time high of $342.32 million, reached on September 30, 2023.
Performance
ALNY quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$75.39M-$32.80M(-77.01%)Summary
- As of today (May 29, 2025), ALNY TTM free cash flow is -$75.39 million, with the most recent change of -$32.80 million (-77.01%) on March 31, 2025.
- Over the past year, ALNY TTM FCF has dropped by -$203.21 million (-158.98%).
- ALNY TTM FCF is now -123.64% below its all-time high of $318.87 million, reached on June 30, 2024.
Performance
ALNY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
ALNY Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -201.5% | -34.7% | -159.0% |
| 3 y3 years | +94.1% | +32.7% | +88.5% |
| 5 y5 years | +89.8% | +52.1% | +83.3% |
ALNY Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -201.5% | +94.1% | -137.2% | +32.7% | -123.6% | +88.6% |
| 5 y | 5-year | -201.5% | +94.1% | -137.2% | +52.1% | -123.6% | +91.3% |
| alltime | all time | -122.6% | +94.1% | -137.2% | +52.1% | -123.6% | +91.3% |
ALNY Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$127.28M(+22.7%) | -$75.39M(+77.0%) |
| Dec 2024 | -$42.59M(-201.5%) | -$103.76M(-362.6%) | -$42.59M(-365.1%) |
| Sep 2024 | - | $39.52M(-66.0%) | $16.06M(-95.0%) |
| Jun 2024 | - | $116.14M(-222.9%) | $318.87M(+149.5%) |
| Mar 2024 | - | -$94.49M(+109.5%) | $127.82M(+204.7%) |
| Dec 2023 | $41.95M(-106.8%) | -$45.10M(-113.2%) | $41.95M(-163.0%) |
| Sep 2023 | - | $342.32M(-557.0%) | -$66.56M(-87.7%) |
| Jun 2023 | - | -$74.91M(-58.5%) | -$540.68M(-10.6%) |
| Mar 2023 | - | -$180.37M(+17.4%) | -$604.65M(-1.4%) |
| Dec 2022 | -$613.33M(-14.6%) | -$153.61M(+16.6%) | -$613.33M(-2.9%) |
| Sep 2022 | - | -$131.79M(-5.1%) | -$631.75M(-4.3%) |
| Jun 2022 | - | -$138.87M(-26.5%) | -$660.05M(+0.9%) |
| Mar 2022 | - | -$189.05M(+9.9%) | -$654.28M(-8.9%) |
| Dec 2021 | -$718.07M(+4.8%) | -$172.03M(+7.5%) | -$718.07M(+3.9%) |
| Sep 2021 | - | -$160.10M(+20.3%) | -$690.85M(+5.7%) |
| Jun 2021 | - | -$133.10M(-47.4%) | -$653.50M(-2.8%) |
| Mar 2021 | - | -$252.84M(+74.6%) | -$672.38M(-1.9%) |
| Dec 2020 | -$685.32M(+63.7%) | -$144.81M(+18.0%) | -$685.32M(-11.6%) |
| Sep 2020 | - | -$122.74M(-19.2%) | -$775.29M(-11.0%) |
| Jun 2020 | - | -$151.99M(-42.8%) | -$871.24M(+92.8%) |
| Mar 2020 | - | -$265.78M(+13.2%) | -$451.80M(+7.9%) |
| Dec 2019 | -$418.58M(-39.3%) | -$234.78M(+7.4%) | -$418.58M(+12.6%) |
| Sep 2019 | - | -$218.69M(-181.8%) | -$371.77M(+5.5%) |
| Jun 2019 | - | $267.45M(-215.0%) | -$352.30M(-52.7%) |
| Mar 2019 | - | -$232.56M(+23.7%) | -$745.14M(+8.1%) |
| Dec 2018 | -$689.50M(+41.6%) | -$187.97M(-5.6%) | -$689.50M(+10.3%) |
| Sep 2018 | - | -$199.22M(+58.9%) | -$625.30M(+13.7%) |
| Jun 2018 | - | -$125.39M(-29.1%) | -$550.13M(+4.3%) |
| Mar 2018 | - | -$176.92M(+42.9%) | -$527.43M(+8.3%) |
| Dec 2017 | -$487.00M(+30.8%) | -$123.77M(-0.2%) | -$487.00M(+5.5%) |
| Sep 2017 | - | -$124.04M(+20.8%) | -$461.44M(+6.5%) |
| Jun 2017 | - | -$102.70M(-24.8%) | -$433.23M(+4.8%) |
| Mar 2017 | - | -$136.48M(+39.0%) | -$413.30M(+11.0%) |
| Dec 2016 | -$372.26M(+84.2%) | -$98.22M(+2.5%) | -$372.26M(+12.7%) |
| Sep 2016 | - | -$95.83M(+15.8%) | -$330.20M(+11.9%) |
| Jun 2016 | - | -$82.77M(-13.3%) | -$295.21M(+9.7%) |
| Mar 2016 | - | -$95.44M(+69.9%) | -$269.16M(+33.2%) |
| Dec 2015 | -$202.09M(+15.7%) | -$56.16M(-7.7%) | -$202.09M(+8.6%) |
| Sep 2015 | - | -$60.84M(+7.3%) | -$186.09M(+10.0%) |
| Jun 2015 | - | -$56.72M(+100.0%) | -$169.15M(+5.1%) |
| Mar 2015 | - | -$28.36M(-29.4%) | -$160.90M(-7.8%) |
| Dec 2014 | -$174.60M | -$40.16M(-8.5%) | -$174.60M(+10.7%) |
| Sep 2014 | - | -$43.90M(-9.4%) | -$157.69M(+15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$48.48M(+15.2%) | -$136.45M(+21.9%) |
| Mar 2014 | - | -$42.06M(+80.9%) | -$111.96M(+54.1%) |
| Dec 2013 | -$72.66M(-41.4%) | -$23.25M(+2.6%) | -$72.66M(-38.9%) |
| Sep 2013 | - | -$22.66M(-5.5%) | -$119.01M(+22.9%) |
| Jun 2013 | - | -$23.98M(+765.7%) | -$96.87M(+0.6%) |
| Mar 2013 | - | -$2.77M(-96.0%) | -$96.25M(-22.4%) |
| Dec 2012 | -$123.96M(+40.3%) | -$69.60M(>+9900.0%) | -$123.96M(+54.9%) |
| Sep 2012 | - | -$517.00K(-97.8%) | -$80.04M(-26.4%) |
| Jun 2012 | - | -$23.36M(-23.3%) | -$108.81M(-3.3%) |
| Mar 2012 | - | -$30.48M(+18.7%) | -$112.50M(+27.3%) |
| Dec 2011 | -$88.36M(-0.8%) | -$25.68M(-12.3%) | -$88.36M(+4.9%) |
| Sep 2011 | - | -$29.29M(+8.3%) | -$84.20M(+5.2%) |
| Jun 2011 | - | -$27.05M(+327.2%) | -$80.02M(+1.7%) |
| Mar 2011 | - | -$6.33M(-70.6%) | -$78.71M(-11.6%) |
| Dec 2010 | -$89.07M(+15.5%) | -$21.53M(-14.3%) | -$89.07M(+4.0%) |
| Sep 2010 | - | -$25.11M(-2.5%) | -$85.68M(+4.6%) |
| Jun 2010 | - | -$25.74M(+54.2%) | -$81.90M(-12.1%) |
| Mar 2010 | - | -$16.70M(-7.9%) | -$93.14M(+20.8%) |
| Dec 2009 | -$77.09M(-240.9%) | -$18.13M(-15.0%) | -$77.09M(+18.4%) |
| Sep 2009 | - | -$21.32M(-42.3%) | -$65.09M(+4.9%) |
| Jun 2009 | - | -$36.98M(+5554.6%) | -$62.06M(-194.5%) |
| Mar 2009 | - | -$654.00K(-89.3%) | $65.68M(+20.0%) |
| Dec 2008 | $54.73M(-71.0%) | -$6.13M(-66.5%) | $54.73M(+13.6%) |
| Sep 2008 | - | -$18.29M(-120.2%) | $48.19M(-83.4%) |
| Jun 2008 | - | $90.75M(-882.2%) | $290.08M(+53.1%) |
| Mar 2008 | - | -$11.60M(-8.4%) | $189.44M(+0.4%) |
| Dec 2007 | $188.73M(-737.3%) | -$12.67M(-105.7%) | $188.73M(-4.0%) |
| Sep 2007 | - | $223.60M(-2361.8%) | $196.50M(-738.3%) |
| Jun 2007 | - | -$9.89M(-19.7%) | -$30.78M(-3.0%) |
| Mar 2007 | - | -$12.31M(+151.1%) | -$31.74M(+7.2%) |
| Dec 2006 | -$29.62M(+60.7%) | -$4.90M(+33.3%) | -$29.62M(+36.5%) |
| Sep 2006 | - | -$3.68M(-66.1%) | -$21.70M(-11.8%) |
| Jun 2006 | - | -$10.85M(+6.5%) | -$24.60M(+20.8%) |
| Mar 2006 | - | -$10.19M(-437.8%) | -$20.37M(+10.5%) |
| Dec 2005 | -$18.43M(-35.5%) | $3.02M(-145.8%) | -$18.43M(-22.7%) |
| Sep 2005 | - | -$6.58M(-0.5%) | -$23.85M(+8.1%) |
| Jun 2005 | - | -$6.62M(-19.7%) | -$22.06M(-15.8%) |
| Mar 2005 | - | -$8.25M(+242.9%) | -$26.19M(-8.4%) |
| Dec 2004 | -$28.58M(+79.2%) | -$2.40M(-49.8%) | -$28.58M(+9.2%) |
| Sep 2004 | - | -$4.79M(-55.4%) | -$26.17M(+22.4%) |
| Jun 2004 | - | -$10.75M(+1.1%) | -$21.38M(+101.1%) |
| Mar 2004 | - | -$10.63M | -$10.63M |
| Dec 2003 | -$15.95M(+766.7%) | - | - |
| Dec 2002 | -$1.84M | - | - |
FAQ
- What is Alnylam Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual FCF year-on-year change?
- What is Alnylam Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly FCF year-on-year change?
- What is Alnylam Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals TTM FCF year-on-year change?
What is Alnylam Pharmaceuticals annual free cash flow?
The current annual FCF of ALNY is -$42.59M
What is the all time high annual FCF for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual free cash flow is $188.73M
What is Alnylam Pharmaceuticals annual FCF year-on-year change?
Over the past year, ALNY annual free cash flow has changed by -$84.53M (-201.54%)
What is Alnylam Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of ALNY is -$127.28M
What is the all time high quarterly FCF for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly free cash flow is $342.32M
What is Alnylam Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, ALNY quarterly free cash flow has changed by -$32.80M (-34.71%)
What is Alnylam Pharmaceuticals TTM free cash flow?
The current TTM FCF of ALNY is -$75.39M
What is the all time high TTM FCF for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high TTM free cash flow is $318.87M
What is Alnylam Pharmaceuticals TTM FCF year-on-year change?
Over the past year, ALNY TTM free cash flow has changed by -$203.21M (-158.98%)